Posición de corea del sur hacia el uso terapéutico de células madre (inglés)
Páginas: 2 (375 palabras)
Publicado: 24 de febrero de 2011
Delegation: South Korea
FORMAT
The stem cell research and investigation has been a polemic issue since scientists began talking about it. South Korea has been a pioneer in the research and useof stem cells. South Korea, after having its issues with the misinformation published by Dr. Hwang, agreed to sign the Bioethics and Biosafety Act in 2005, to ensure the use of ethics in scientificresearch.
South Korea has spent around $60 million, in both private and governmental sector, on this type of research. [1] When in 2005, the experiments of Dr. Hwang already showed discoveries aboutthe cloning of stem cells which could lead to the cure of many diseases all over the world. South Korea is aware that the research of stem cells could eventually lead to human cloning, but with theBioethics and Biosafety Act effective my delegation opposes to human cloning. The cloning of human embryos is allowed only for research means. Also, experimentation is allowed in some already existingembryo research.[2] Our government supports the research in adult stem cell research. IVR’s (in-vitro reproduction) are allowed in the country for reproductive means. With a successful use of stemcells: diseases like leukemia, other types of cancer, brain damages, heart and spinal cord damages, Alzheimer’s, and Parkinson’s disease could be cured. There is one death caused by cancer every 4seconds in the world,[3] while coronary heart diseases occupy the leading cause of death in the world.[4]
It is important that all nations agree to the research and use of stem cells to find cures forthese diseases that are causing now a days the deaths of many people. But it is importante that we do this in the most human way, that’s why my delegation proposes an international agreement on the useof ethics in the research of these experiments.
-----------------------
[1] Richard Gardner and Tim Watson, “A Patchwork of Laws,” Scientific American (July
2005), p. A21. 23/1/11
[2] CRS...
FORMAT
The stem cell research and investigation has been a polemic issue since scientists began talking about it. South Korea has been a pioneer in the research and useof stem cells. South Korea, after having its issues with the misinformation published by Dr. Hwang, agreed to sign the Bioethics and Biosafety Act in 2005, to ensure the use of ethics in scientificresearch.
South Korea has spent around $60 million, in both private and governmental sector, on this type of research. [1] When in 2005, the experiments of Dr. Hwang already showed discoveries aboutthe cloning of stem cells which could lead to the cure of many diseases all over the world. South Korea is aware that the research of stem cells could eventually lead to human cloning, but with theBioethics and Biosafety Act effective my delegation opposes to human cloning. The cloning of human embryos is allowed only for research means. Also, experimentation is allowed in some already existingembryo research.[2] Our government supports the research in adult stem cell research. IVR’s (in-vitro reproduction) are allowed in the country for reproductive means. With a successful use of stemcells: diseases like leukemia, other types of cancer, brain damages, heart and spinal cord damages, Alzheimer’s, and Parkinson’s disease could be cured. There is one death caused by cancer every 4seconds in the world,[3] while coronary heart diseases occupy the leading cause of death in the world.[4]
It is important that all nations agree to the research and use of stem cells to find cures forthese diseases that are causing now a days the deaths of many people. But it is importante that we do this in the most human way, that’s why my delegation proposes an international agreement on the useof ethics in the research of these experiments.
-----------------------
[1] Richard Gardner and Tim Watson, “A Patchwork of Laws,” Scientific American (July
2005), p. A21. 23/1/11
[2] CRS...
Leer documento completo
Regístrate para leer el documento completo.